Loading organizations...
§ Venture Capital · Valencia, Spain
Investment fund manager investing in early-stage tech transfer projects and companies, focused on bio-health, food tech, and industrial sectors.
Clave Capital is an independent investment fund manager based in Pamplona, Spain, that invests in early-stage companies and technology transfer projects across the biotechnology, healthtech, food technology, and industrial sectors. The firm has invested approximately €90 million across its portfolio and completed more than 90 investment projects over its operational history. Operating across multiple sectors, the firm manages several specialized investment vehicles, including the €80 million Clave Innohealth fund focused on disruptive bio-health initiatives. The organization's investment strategies and regional delegations are guided by key partners and directors such as Fernando Frauca Amorena, Alberto Bermejo, Antonio Tornero, and Cesar Mendoza. The firm recently expanded its national footprint by establishing a fourth office at the Barcelona Science Park to oversee its healthcare investments. Clave Capital was originally founded in 2001 in the region of Navarra, Spain.
Key people at Clave Capital.
Clave Capital has 6 tracked investments across 4 companies. The latest tracked deal is $3.0M Series U in Corify Care in December 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2024 | Corify Care | $3.0M Series U | — | — |
| Jun 1, 2024 | inBiot Monitoring | $540K Series U | — | — |
| Nov 27, 2023 | MiMARK | $4.6M Seed | — | Canterbury Scientific, Cdti, EIC Fund, Inveready, Namarel Ventures, Nara Capital, Wa4steam |
| Oct 30, 2023 | Shakers | $6.3M Seed | — | Adevinta Ventures, Athos Capital, Brighteye Ventures, CDTI Innvierte, Wayra |
| Oct 14, 2021 | Shakers | $927K Debt / Other Equity | Clave Capital | Mondrag |
| Jul 1, 2021 | Corify Care | $1.0M Seed | — | — |
Key people at Clave Capital.
High-Level OverviewClave Capital is a venture capital and investment management firm with over 16 years of experience, specializing in strategic investments in innovative projects and industrial SMEs across sectors such as technology, renewable energy, agri-food, healthcare, and manufacturing. Their investment philosophy centers on active engagement and collaboration with founders and management teams to create value and foster growth. Recently, they launched an €80 million fund focused on health-related sectors including medtech, ehealth, nutrition, and biotech. Clave Capital plays a significant role in the startup ecosystem by supporting technology transfer projects and encouraging close cooperation among investors, developers, and entrepreneurs to address emerging market demands effectively[1][2][5].
Origin StoryClave Capital was founded over 16 years ago and is headquartered in Spain, with offices in Madrid and Pamplona. The firm has evolved from focusing primarily on industrial SMEs and technology transfer projects to expanding its scope into health innovation and renewable energy. Key partners include experienced investment managers and directors such as Alberto Bermejo, Antonio Tornero, Cesar Mendoza, and Fernando Frauca Amorena. In December 2024, a related Brazil-based Clave Capital entity became an affiliate of BTG Pactual Asset Management, indicating a growing international presence and strategic evolution[1][3][5].
Core Differentiators- Unique Investment Model: Combines strategic capital with active operational involvement to accelerate portfolio company growth.- Network Strength: Strong collaborative partnerships with founders, management teams, investors, and the broader innovation ecosystem.- Track Record: Over 90 investments with a focus on industrial SMEs, technology transfer, and recently health innovation.- Operating Support: Emphasis on team integration and hands-on support in strategy and management to meet market demands effectively[1][2][5].
Role in the Broader Tech LandscapeClave Capital rides the trend of integrating venture capital with industrial innovation and technology transfer, addressing the growing need for sustainable and health-related technological solutions. The timing is favorable due to increasing global emphasis on renewable energy, healthcare innovation, and digital transformation. By fostering close collaboration among stakeholders, Clave Capital influences the broader ecosystem by bridging gaps between traditional industries and emerging tech startups, thus accelerating innovation diffusion and market adoption[1][2][5].
Quick Take & Future OutlookGoing forward, Clave Capital is poised to deepen its impact in health tech and renewable energy sectors, leveraging its new €80 million health-focused fund. Trends such as digital health, biotech advancements, and sustainability will likely shape its investment priorities. As the firm continues to expand its network and operational expertise, its influence on early-stage innovation and industrial SMEs is expected to grow, reinforcing its role as a strategic partner in the evolving European and Latin American venture capital landscapes[2][3][5]. This trajectory ties back to their foundational commitment to active engagement and value creation in innovative projects.
